Viewing Gene With Clinical Trials Data

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Report Bug Request Feature
Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol: FGR
Name: FGR proto-oncogene Src family tyrosine kinase
Location: 01p35.3
Locus Group: protein-coding gene
Gene Type: Protein Coding
Locus Type: gene with protein product
ID+ Clinical Trials CompTox DrugMatrix Conditions Design Enrollment Locations Outcomes
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT03200665 Sonographic Evaluation of Fetal Growth in the Third Trimester of Low-risk Pregnancy a Randomized Trial View
NCT01981824 Prediction of Growth Restricted Fetuses Using Femur Length to Mid-thigh Circumference Ratio A Case-control Study View
NCT02097667 EVERREST Developing a Therapy for Fetal Growth Restriction View
NCT02277132 The Dutch STRIDER Sildenafil TheRapy In Dismal Prognosis Early-onset Fetal Growth Restriction View
NCT02678221 Sildenafil Citrate for the Management of Asymmetrical Intrauterine Growth Restriction View
NCT02964793 Effects of Serial Plotting on Fundal Height Charts on Identification and Outcomes of Small for Gestational Age Infants View
NCT04215107 Fetal Distribution of Feto-placental Blood Flow Related to Placental Nutrient Transport and Maternal Food Intake View
NCT05601375 Speckle Tracking Echocardiography in Infants Prenatally and Postnatally View
NCT05059093 Developing and Testing AI Models for Fetal Biometry and Amniotic Volume Assessment in Fetal Ultrasound Scans View
NCT05123677 Cardiac Output Monitoring to Predict Pre-Eclampsia and Restricted Growth COMPaRE View
NCT04447248 qCTG and Doppler Ultrasound in the Detection of Hypoxia Among FGR Fetuses View
NCT04535804 Aspirin in the Treatment of Pregnant Women With Adenomyosis on Reducing Preterm Delivery View
NCT00166660 Preterm Fetal Growth Restriction and Developmental Care View
NCT01107782 Sildenafil and Uteroplacental Perfusion View
NCT05034861 COmputerized CTG Self-MOnitoring Versus Standard Doppler Assessment in Late-onset FGR COSMOS Study View
NCT02245477 Maternal Serum Vascular Endothelial Growth Factor in Pregnant Women With Foetal Growth Restriction View
NCT05622838 Maternal alpha1 Antitrypsin as a Marker of Intrauterine Growth Restriction in Pre-eclamptic Women View
NCT02442492 Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction View
NCT05606497 OPtimal TIming of COrticosteroids in Early-onset Fetal Growth REstriction the OPTICORE Study View
NCT05651347 Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction View
NCT04720690 Bioimpedence and Arterial Function Monitoring at Birth and in Infants View
NCT06381258 Fetal Cardiac Function View
NCT04084990 Sleep Apnea and Fetal Growth Restriction View
NCT04125446 Genomic and Epigenomic Alterations After Cancer Treatment in Pregnancy View
NCT04228627 Ferritin Screening And IRon Treatment for Maternal Anemia and FGR Prevention Trial View
NCT04288037 Fetal Heart Rate Variability and Fetal Growth Restriction View
NCT05696223 Doppler at the Diagnosis in Predicting Perinatal Outcomes in Early and Late-onset Fetal Growth Restriction View
NCT04394611 Metals and in Fetal Growth Restriction View
NCT06010238 STV Analysis Versus Visual Evaluation of Cardiotocography in FGR View
NCT05774236 Cooks Balloon Versus Dinoprostone for Labor Induction of Term Pregnancies With Fetal Growth Restriction View
NCT04557475 Transplacental Aspirin Therapy for Early Onset Fetal Growth Restriction View
NCT05806372 Biomarkers of CVD Dysfunction in Hypertensive Disorders of Pregnancy View
NCT05814198 Evaluation of HALP Score in Distinction Between FGR and SGA View
NCT04762992 LMWH for Treatment of Early Fetal Growth Restriction HepaGrowth View
NCT04839185 Placental Lesions in Fetal Growth Restrictions View
NCT06372938 Role of Inflammatory Markers and Doppler Parameters in Late-Onset Fetal Growth Restriction A Machine Learning Approach View
NCT04933396 FGR Diagnostic Criteria in Predicting Adverse Neonatal Outcomes View
NCT05295667 Doppler and AFV for Outcome Prediction ın FGR View
NCT05423665 Speckle Tracking Echocardiography as a Tool for Early Diagnosis of Impaired Fetal Growth Twin Pregnancies View
NCT01995968 Antenatal Detection of Fetal Growth Restriction and Stillbirths Rate View
NCT05820464 Diastolic Deceleration Area in Early-onset FGR View
NCT05837195 Diastolic Deceleration Area in Late-onset FGR View
NCT05938829 Fetal Growth Restriction Management Using Two Guidelines - Fetal Growth Antenatal Management Evaluation View
NCT06096805 Prediction of Placental Fetal Growth Restriction in High Risk Population PoPFGR View
NCT06104748 A Cohort of Maternal Vascular Malperfusion-related FGR CoMVMFGR View
NCT06215690 Evaluation of Anterior Middle Brain Structures With Cerebrovascular Flow in Fetuses With Fetal Growth Restriction View
NCT06343051 USCOM in Newly Diagnosed FGR Cases View
NCT06497205 AMBulatory Fetal ECG Monitoring in Low and High-Risk Pregnancies View
NCT00870779 Fluorescence Guided Resection of Brain Tumors View
NCT03067298 Prediction of Preeclampsia and Other Pregnancy Complications Following Combined Iterative Screening View
NCT03153215 Sildenafil in Sever Intrauterine Growth Retardation View
NCT03669185 Pentaerithrityl Tetranitrate PETN for Secondary Prevention of Intrauterine Growth Restriction View